Anlotinib has been investigated for the treatment of Non-small Cell Lung Cancer and Metastatic Colorectal Cancer.
用于治疗非小细胞肺癌、结直肠癌、肾癌、软组织肉瘤、甲状腺癌、胃癌等。
用于无法手术的局部晚期或转移性甲状腺髓样癌患者的治疗。
The 307th Hospital of Chinese People's Liberation Army, Beijing, Beijing, China
Guangdong General Hospital, Guangzhou, Guangdong, China
Hunan Cancer Hospital, Changsha, Hunan, China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Jiangsu province tumor hospital, Nanjing, Jiangsu, China
Beijing Tongren Hospital, Beijing, Beijing, China
Peking Union Medical College Hospital, Beijing, Beijing, China
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Harbin medical university affiliated tumor hospital, Harbin, Heilongjiang, China
Peking Union Medical College Hospital, Beijing, Beijing, China
The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China
The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China
Fourth Hospital of Hebei Medical University Tumor Hospital of Hebei Province, Shijiazhuang, Hebei, China
Gansu Cancer Hospital, Lanzhou, Gansu, China
Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
Guangxi medical university affiliated tumor hospital, Nanning, Guangxi, China
Xinqiao Hospital, Chongqing, Chongqing, China
Gansu Provincial People 's Hospital, Lanzhou, Gansu, China
First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.